Ads
related to: cara stock priceinvesco.com has been visited by 100K+ users in the past month
Search results
Wall Street Analysts See a 133% Upside in Cara (CARA): Can the Stock Really Move This High?
Zacks via Yahoo Finance· 2 years agoThe mean of analysts' price targets for Cara (CARA) points to a 132.9% upside in the stock. While...
Cara Therapeutics (NASDAQ:CARA shareholders incur further losses as stock declines 8.8% this week,...
Simply Wall St. via Yahoo Finance· 1 year agoFor many investors, the main point of stock picking is to generate higher returns than the overall...
CARA's Late-Stage Skin Disease Study Fails, Stock Plummets 49%
Zacks via Yahoo Finance· 5 months agoCARA discontinues the clinical program of oral difelikefalin for pruritus associated with atopic...
Cara Therapeutics (CARA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zacks via Yahoo Finance· 2 years agoCara (CARA) possesses the right combination of the two key ingredients for a likely earnings beat in...
Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 65%
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Institutions' substantial holdings in Cara Therapeutics implies that they have...
Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 3 weeks agoCara (CARA) delivered earnings and revenue surprises of -47.37% and 5.11%, respectively, for the...
Cara Therapeutics, Inc. (NASDAQ:CARA) Analysts Just Cut Their EPS Forecasts Substantially
Simply Wall St. via Yahoo Finance· 1 year agoMarket forces rained on the parade of Cara Therapeutics, Inc. (NASDAQ:CARA) shareholders today, when...
Cara Therapeutics, Inc.'s (NASDAQ:CARA) P/S Is On The Mark
Simply Wall St. via Yahoo Finance· 1 year agoYou may think that with a price-to-sales (or "P/S") ratio of 4.4x Cara Therapeutics, Inc....
The past five years for Cara Therapeutics (NASDAQ:CARA) investors has not been profitable
Simply Wall St. via Yahoo Finance· 12 months agoSome stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss....
News Flash: Analysts Just Made A Substantial Upgrade To Their Cara Therapeutics, Inc. (NASDAQ:CARA)...
Simply Wall St. via Yahoo Finance· 7 months agoCara Therapeutics, Inc. (NASDAQ:CARA) shareholders will have a reason to smile today, with the...
